RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles see all

Displaying items 1-5
  • American Ebola patients treated with ZMapp experimental drug

    American Ebola patients treated with ZMapp experimental drug
    An American doctor who contracted Ebola treating victims of the deadly virus in Liberia has recovered and has been discharged Thursday by the Atlanta hospital that treated him with an experimental drug.
  • Pfizer back for AstraZeneca? Year-end move seen most likely

    LONDON (Reuters) - Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion (71 billion pounds) takeover attempt in May. But while...

    Experimental Ebola drugs needed for 'up to 30,000 people'

    LONDON (Reuters) - Up to 30,000 people could have used experimental treatments or vaccines so far in the world's worst outbreak of Ebola currently plaguing West Africa, British scientists said on Wednesday. The calculation highlights the dilemma facing...

    Amicus's lead drug nears approval as late-stage trial succeeds

    (Reuters) - Amicus Therapeutics Inc moved a step closer to bringing its first drug to the market after trial results paved the way for its lead drug to become the first oral treatment for patients with a disorder that causes an abnormal build-up of fat....

    Sanford-Burnham taps new CEO from pharma industry

    Sanford-Burnham taps new CEO from pharma industry
    With the selection of Perry Nisen as its new chief executive officer today, Sanford-Burnham Medical Research Institute is signaling a commitment to its new long-term strategic vision of open collaboration for the development of breakthrough clinical...